TipRanks

Nadav Kidron Insider Profile

11 Followers
Nadav Kidron, President & CEO, Director at Oramed Pharm, holds 4.27M shares in Oramed Pharm (Ticker: ORMP), holds 30.00K shares in Nano Dimension (Ticker: NNDM), holds 7.66K shares in Lifeward (Ticker: LFWD).
tipranks
Nadav Kidron

Nadav Kidron
Oramed Pharm (ORMP)
President & CEO, Director

Ranked #8,735 out of 109,349 Corporate Insiders

Profitable Transactions

88%
7 out of 8 Profitable Transactions

Average Return

+27.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$18M
99.51%
0.26%
0.23%
A breakdown of Nadav Kidron's holdings

Insider Roles

Oramed Pharm
(ORMP)
President & CEO, Director
Lifeward
(LFWD)
Director
Nano Dimension
(NNDM)
Director
Roles that Nadav Kidron holds in companies

Most Profitable Insider Trade

Stock:
Oramed Pharm
(ORMP)
Rating:Informative Buy
Date:Mar 20, 2015 - Mar 20, 2016
Return:+57.00%
The most profitable trade made by Nadav Kidron

Nadav Kidron's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Oramed Pharm
Sep 25, 2026
President & CEO, Director
Uninformative Buy
―
$17.54M
Lifeward
Mar 27, 2026
Director
Uninformative Buy
―
$45.57K
Nano Dimension
Aug 25, 2026
Director
Informative Sell
15.00K
$39.90K
List of latest transactions for each holding click on a transaction to see Nadav Kidron's performance on stock

Nadav Kidron insider profile FAQ

What is the percentage of profitable transactions made by Nadav Kidron?
The percentage of profitable transactions made by Nadav Kidron is 88%.
    What is the average return per transaction made by Nadav Kidron?
    The average return per transaction made by Nadav Kidron is 27.10%.
      What stocks does Nadav Kidron hold?
      Nadav Kidron holds: ORMP, LFWD, NNDM stocks.
        What was Nadav Kidron’s latest transaction?
        Nadav Kidron latest transaction was an Uninformative Buy of ―.
          What was Nadav Kidron's most profitable transaction?
          Nadav Kidron’s most profitable transaction was an Informative Buy of ORMP stock on March 20, 2015. The return on the trade was 57.00%.
            What is Nadav Kidron's role in Oramed Pharm?
            Nadav Kidron's role in Oramed Pharm is President & CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.